Excretion of L-dopa and its metabolites in urine of Parkinson's disease patients receiving L-dopa therapy.
D000368:Aged; D000535:Aluminum; D002845:Chromatography; D002852:Chromatography, Ion Exchange; D003124:Colorimetry; D004295:Dihydroxyphenylalanine / Q000378:metabolism* / Q000627:therapeutic use* / Q000652:urine; D004298:Dopamine / Q000652:urine; D004586:Electrophoresis; D004837:Epinephrine / Q000652:urine; D005260:Female; D005470:Fluorometry; D006801:Humans; D008297:Male; D008722:Methods; D008875:Middle Aged; D009638:Norepinephrine / Q000652:urine; D009647:Normetanephrine / Q000652:urine; D010087:Oxides; D010209:Paper; D010300:Parkinson Disease / Q000188:drug therapy* / Q000652:urine; D010648:Phenylacetates / Q000652:urine; D014642:Vanilmandelic Acid / Q000652:urine
D010087:Oxides; D010648:Phenylacetates; D009647:Normetanephrine; D014642:Vanilmandelic Acid; D004295:Dihydroxyphenylalanine; D000535:Aluminum; D004298:Dopamine; D009638:Norepinephrine; D004837:Epinephrine